Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Department of Radiation Oncology, University Hospitals Gießen and Marburg (UKGM), Gießen, Germany; FB20 Medicine, Philipps-University Marburg, Marburg, Germany.
Transplant Cell Ther. 2021 Oct;27(10):876.e1-876.e11. doi: 10.1016/j.jtct.2021.06.025. Epub 2021 Jun 30.
In multiple myeloma, local radiation therapy (RT) of osseous lesions before peripheral blood stem cell (PBSC) mobilization is assumed to impair the PBSC mobilization and collection. However, the results of previously published studies are inconsistent and do not evaluate detailed metrics of RT and PBSC outcome parameters. In total, 352 patients undergoing PBSC mobilizations and RT in first-line treatment were evaluated. Patients were grouped into RT (n = 283) and no RT (n = 69) before PBSC mobilization. Except for the International Staging System score, both groups were homogeneous regarding the first diagnosis characteristics, first-line treatments, and response parameters. RT metrics (RT yes versus no, volume of irradiated hematopoietic bone marrow [BM], biologically equivalent doses in 2 Gy fractions [EQD2]) were analyzed for the following PBSC outcome parameters: achievement of the PBSC collection goal, CD34+ cell collection yield, duration of the mobilization phase, and number of leukapheresis (LP) sessions to reach the collection goal. No statistically significant differences in the percentage of collection failures to reach at least 3 sufficient PBSC transplants were identified comparing patients with (n = 32 [11%]) and without RT (n = 4 [6%]) before PBSC mobilization (P = .265). However, patients with RT before PBSC mobilization showed a significant prolongation of the PBSC mobilization (median 1 day, P =.026) and required a higher number of LP sessions to reach the collection goal (median 1 LP, P < .001) compared with patients who received RT after PBSC mobilization. Moreover, patients with RT before PBSC mobilization reached a significantly lower CD34+ cell collection result (mean 8.94 versus 9.81 × 10/kg body weight [bw], P = .002). No correlation was identified between the overall CD34+ cell yield and the volume of irradiated hematopoietic BM or EQD2, respectively. In the RT before PBSC mobilization group, patients who required more than 1 LP session to reach the PBSC collection goal after RT had a significantly higher percentage of radiated hematopoietic BM compared to those who required only 1 LP session (mean 9.7% versus 7.2%, P = .002). Overall, our study indicates a negative impact of RT on PBSC mobilization and collection. Apart from emergency settings, it might be beneficial to postpone RT to a post-PBSC collection time point. © 2021 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
在多发性骨髓瘤中,人们认为在采集外周血干细胞 (PBSC) 之前对骨病变进行局部放射治疗 (RT) 会损害 PBSC 的动员和采集。然而,先前发表的研究结果并不一致,并且没有评估 RT 和 PBSC 结果参数的详细指标。本研究共评估了 352 例在一线治疗中接受 PBSC 动员和 RT 的患者。患者被分为 RT 组 (n = 283) 和无 RT 组 (n = 69)。除国际分期系统评分外,两组在首次诊断特征、一线治疗和反应参数方面均具有同质性。分析了 RT 指标 (RT 是与否、照射造血骨髓的体积、2 Gy 分数的生物等效剂量 [EQD2]) 对以下 PBSC 结果参数的影响:达到 PBSC 采集目标、CD34+细胞采集产量、动员阶段持续时间以及达到采集目标所需的白细胞分离术 (LP) 次数。在比较接受 PBSC 动员前有 (n = 32 [11%]) 和无 RT (n = 4 [6%]) 的患者,发现达到至少 3 次足够 PBSC 移植的采集失败百分比没有统计学显著差异 (P =.265)。然而,与接受 PBSC 动员后接受 RT 的患者相比,在 PBSC 动员前接受 RT 的患者 PBSC 动员明显延长 (中位数 1 天,P =.026),并且需要更多的 LP 次数才能达到采集目标 (中位数 1 LP,P <.001)。此外,在 PBSC 动员前接受 RT 的患者 CD34+细胞采集结果明显较低 (平均 8.94 与 9.81×10/kg 体重 [bw],P =.002)。未发现整体 CD34+细胞产量与照射造血 BM 或 EQD2 体积之间存在相关性。在 PBSC 动员前接受 RT 的患者中,需要进行超过 1 次 LP 才能达到 PBSC 采集目标的患者与仅需要进行 1 次 LP 的患者相比,照射造血 BM 的比例明显更高 (平均 9.7%比 7.2%,P =.002)。总的来说,我们的研究表明 RT 对 PBSC 动员和采集有负面影响。除紧急情况外,将 RT 推迟到 PBSC 采集后时间点可能会更有益。